packageRasagiline

rasagiline

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Rasagiline is a monoamine oxidase B inhibitor used to treat Parkinson's disease. It is an approved medicine, authorised in the European Union for Parkinson's disease.

Summary written by glm-5.3-flash from Wikidata Q420685 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:rasagiline
ATC codes:N04BD02
DrugBank:DB01367
PubChem CID:3052776
ChEBI:63620
Wikidata:Q420685
formula:C12H13N
molar mass:171.243 g/mol (PubChem CID 3052776)
logP:1.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown